Value Hunters: Look To Abbott Laboratories (ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of 2.37% and 14.46% over the past three months. ABT shares are trading 14.84% year to date (YTD), with the 12-month market performance up to 22.65% higher. […]
Reviewing The Case For Abbott Laboratories (ABT) Going Higher
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of 1.83% and 11.68% over the past three months. ABT shares are trading 11.59% year to date (YTD), with the 12-month market performance up to 15.68% higher. […]
Now Is A Suitable Moment For A Long-Term Purchase Of Abbott Laboratories (NYSE: ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of -5.88% and 9.65% over the past three months. ABT shares are trading 9.58% year to date (YTD), with the 12-month market performance up to 11.47% higher. […]
Growing Through Challenges? – Abbott Laboratories (ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of 4.28% and 15.08% over the past three months. ABT shares are trading 17.28% year to date (YTD), with the 12-month market performance up to 16.89% higher. […]
Is Abbott Laboratories (NYSE: ABT) Back In The Buying Zone?
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of -0.34% and 13.65% over the past three months. ABT shares are trading 12.47% year to date (YTD), with the 12-month market performance up to 14.09% higher. […]
Abbott Laboratories (NYSE: ABT) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of -4.79% and 10.93% over the past three months. ABT shares are trading 11.66% year to date (YTD), with the 12-month market performance up to 6.27% higher. […]
Look At Analyst Expectations For A Better Read On Abbott Laboratories (NYSE: ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. The company’s stock has a 5-day price change of -3.58% and 14.77% over the past three months. ABT shares are trading 17.28% year to date (YTD), with the 12-month market performance up to 9.71% higher. […]
Growing Through Challenges? – Abbott Laboratories (ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
Value Hunters: Look To Abbott Laboratories (ABT)
Currently, there are 1.73B common shares owned by the public and among those 1.72B shares have been available to trade. Insiders at the company have transacted a total of 73 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 20 of these insider trades were purchases, […]
An Important Check-Up On Abbott Laboratories (NYSE: ABT)
Abbott Laboratories (ABT) concluded trading on Wednesday at a closing price of $112.06, with 3.99 million shares of worth about $447.23 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.78% during that period and on Wednesday the price saw a gain of about […]
